VeriMomIst salix alba/daphnoides/fragilis/purpurea bark extract in der Schwangerschaft sicher?
No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
Related ingredients
Frequently asked questions
- Ist salix alba/daphnoides/fragilis/purpurea bark extract in der Schwangerschaft sicher?
- No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
- Ist salix alba/daphnoides/fragilis/purpurea bark extract während des Stillens sicher?
- No regulatory harmonised flag or authoritative safety assessment (SCCS/CIR) indicating reproductive or lactation hazards for Salix bark extracts. Theoretical transfer of small amounts of salicylates into circulation is possible from topical use, but expected to be low with typical cosmetic use; evidence for clinically relevant transfer into breast milk from cosmetic topical willow-bark is lacking.
- Ist salix alba/daphnoides/fragilis/purpurea bark extract sicher für Babyhaut?
- No evidence that willow bark extract is a reproductive toxicant or teratogen in humans or animals in regulatory reviews. However, infants (0–3 yr) have higher dermal absorption per kg and a less mature barrier: if the extract contains measurable salicylates, exposure is plausibly higher (adult e=1 → infant e incremented to 2). There is limited/no infant-specific safety data for topical willow-bark-containing cosmetics.
- Wie bewertet VeriMom salix alba/daphnoides/fragilis/purpurea bark extract?
- VeriMom bewertet salix alba/daphnoides/fragilis/purpurea bark extract mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu salix alba/daphnoides/fragilis/purpurea bark extract?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu salix alba/daphnoides/fragilis/purpurea bark extract basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.